Discover Authentic Matcha at Toronto's New Café
The Matcha Tokyo opens in Toronto, offering premium matcha drinks and desserts.
The whole archive, filed by the part of life it belongs to — and labelled with how strong the evidence behind it actually is.
Showing 1729–1752 of 3,538
The Matcha Tokyo opens in Toronto, offering premium matcha drinks and desserts.
A partnership aims to enhance investment strategies in longevity and healthspan innovations, potentially benefiting those interested in aging well.
Turning 65 opens up Medicare options that can impact your health and finances.
The U.S. urology workforce faces significant shortages, particularly in rural areas, affecting access to care.
Advocacy groups are pushing for better asthma care access in the U.S.
Glycans, sugar molecules that change with lifestyle, may reveal insights into aging and health risks.
A new fertility treatment, FemaSeed, allows women to receive care in OB/GYN offices, potentially improving access and outcomes for those facing infertility.
Canada has approved a rapid test for hepatitis B that improves access to screening and early diagnosis, crucial for better health outcomes.
Karl Jacob's new book offers practical tips for weight loss by focusing on insulin management instead of calorie counting.
Clearmind Medicine has filed a patent for new non-hallucinogenic compounds aimed at treating PTSD, potentially offering safer mental health solutions.
The LIBERTY robotic system may enhance safety and precision in vascular procedures, benefiting older adults.
The blood banking devices market is set to grow significantly, enhancing blood safety and availability for transfusions.
A new genetic testing method, optical genome mapping, shows promise in diagnosing rare diseases that traditional tests often miss.
A new drug may offer hope for those with TSC-related epilepsy, which affects many people and often resists current treatments.
HealthVerity's acquisition of Symphony Health aims to improve healthcare data integration, potentially leading to better patient care and health outcomes.
Transplants.org is a new resource helping patients navigate organ and stem cell transplants with clear information and support.
The digestive health supplements market is expected to grow significantly, driven by aging populations and increased awareness of gut health.
A new drug may help restore calcium levels in people with a rare genetic condition.
NIVEA offers deodorants tailored for Canada’s climate, focusing on long-lasting protection and skin comfort.
Atea Pharmaceuticals is developing antiviral treatments that may help manage serious viral infections, potentially benefiting overall health as we age.
A new therapy called ipsoprubart may help treat aggressive T cell malignancies, showing promising results in early tests.
A new treatment shows promise in reducing inflammation for people with eosinophilic esophagitis, improving swallowing and quality of life.
KT-579 shows promise as a new oral treatment for inflammatory bowel disease, potentially improving symptoms and overall health.
NRx Pharmaceuticals is starting to manufacture a preservative-free ketamine product to address mental health issues like depression and PTSD, aiming to improve access amid current supply shortages.